BIAFVSGDTC• 7 Days (Normalized)
BIAF vs GDTC (bioAffinity Technologies Inc. vs CytoMed Therapeutics Limited)
Showing Closing Date Range from Sep, 04 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BIAF Performance $7.95
-47.94%
bioAffinity Technologies Inc.
Normalized Baseline0.00%
GDTC Performance $0.78
-9.18%
CytoMed Therapeutics Limited
Normalized Baseline0.00%
Alpha Spread Margin GDTC LEADS
-38.76%
GDTC outperforming by 38.76%
BIAFGDTC
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BIAF GDTC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | BIAF Price | BIAF Gain (%) | GDTC Price | GDTC Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $7.95 | -47.94% | $0.78 | -9.18% | -38.76% |
| Sep 10, 2026 | $9.39 | -38.51% | $0.81 | -5.92% | -32.59% |
| Sep 09, 2026 | $10.50 | -31.24% | $0.80 | -7.67% | -23.57% |
| Sep 08, 2026 | $8.93 | -41.52% | $0.87 | +1.05% | -42.57% |
| Sep 04, 2026 | $15.27 | +0.00% | $0.86 | +0.00% | +0.00% |